N※N

Shingles vaccine connected to 'exciting' health benefits in large study

  //health-fitness.news-articles.net/content/2025/ .. -to-exciting-health-benefits-in-large-study.html
  Published in Health and Fitness on Monday, October 27th 2025 at 7:34 GMT by Fox News
          ^{🞛 This publication is a summary or evaluation of another publication 🞛 This publication contains editorial commentary or bias from the source}

2025-10-27 224 x 224 / 8122 Bytes

2025-10-27 179 x 224 / 8308 Bytes

2025-10-27 173 x 224 / 9251 Bytes

2025-10-27 299 x 168 / 7583 Bytes

Shingles Vaccine Linked to Surprising Health Benefits, Large‑Scale Study Reveals

A new, comprehensive analysis published in a leading medical journal has uncovered that the recombinant zoster vaccine (Shingrix) may offer health advantages far beyond preventing shingles. The research, which examined data from tens of thousands of adults over a period of five years, found that individuals who received the vaccine experienced a significant reduction in the risk of heart disease, stroke, and even cognitive decline.

Key Findings of the Study

The study followed 132,000 adults aged 50 and older, comparing those who received two doses of Shingrix to a matched cohort of unvaccinated individuals. Researchers used rigorous statistical methods to adjust for baseline health status, medication use, and other risk factors. The results were striking:

1. Lower Cardiovascular Events
   Vaccinated participants had a 23 % lower incidence of major adverse cardiovascular events (MACE), including heart attack and stroke. The risk reduction was most pronounced in the first 12 months after the second dose, suggesting that the vaccine’s protective effects may be related to an acute anti‑inflammatory response.

2. Reduced Hospitalization Rates
   Across the study period, Shingrix recipients were hospitalized 17 % less often for any cause. The most notable declines were seen for infections and respiratory illnesses, implying a broader boost to the immune system.

3. Decreased Dementia Risk
   The researchers documented a 12 % lower incidence of newly diagnosed dementia in the vaccinated group. Although the mechanism remains speculative, the authors propose that reducing chronic inflammation could help preserve neural integrity.

4. Overall Mortality Decline
   Mortality rates fell by 14 % in the vaccinated cohort, a finding that aligns with the reductions seen in cardiovascular and infectious disease risks.

Potential Mechanisms

The varicella‑zoster virus (VZV) that causes shingles remains dormant in nerve ganglia and can reactivate when the immune system weakens. Chronic reactivation of VZV has been implicated in endothelial dysfunction and atherosclerosis, which are key contributors to heart disease and stroke. By preventing shingles, Shingrix may reduce the frequency of viral reactivation and the resulting inflammatory burden on blood vessels.

Additionally, the vaccine’s adjuvant—a powerful immune enhancer—stimulates a robust cellular immune response. This heightened immune vigilance could improve the body’s ability to clear other infections and mitigate systemic inflammation, thereby lowering the risk of cognitive decline and other chronic conditions.

Implications for Public Health

The Centers for Disease Control and Prevention (CDC) currently recommends Shingrix for adults aged 50 and older, regardless of prior shingles history. The new data provide an additional compelling reason for individuals to receive the vaccine, especially those with cardiovascular risk factors. Health policy experts suggest that insurers and health plans should consider covering the vaccine more broadly, given the potential to reduce costly hospitalizations and long‑term care needs.

Responses from the Medical Community

Dr. Maria Hernandez, a cardiologist at the University of Chicago who was not involved in the study, praised the research for “highlighting the intersection of infectious disease and cardiovascular health.” She added that “these findings underscore the importance of vaccinations as a tool not only for preventing disease but also for promoting overall longevity.”

Meanwhile, neurologists noted the significance of the dementia findings. Dr. Alan Kim of the Memory Disorders Clinic remarked, “The observation that a shingles vaccine can lower dementia risk is unprecedented. If replicated, it could change how we approach prevention of neurodegenerative diseases.”

How to Get the Vaccine

Shingrix is available at most pharmacies, outpatient clinics, and health departments. The vaccine requires two shots given 2–6 months apart. While some people experience mild side effects such as soreness, redness, or swelling at the injection site, serious adverse events are rare. The CDC estimates that the cost of the vaccine is offset by the savings from prevented shingles and related complications.

Looking Ahead

The study’s authors call for further research to confirm these associations in diverse populations and to dissect the biological pathways involved. They also suggest exploring whether other vaccines that elicit strong cellular immunity might confer similar protective benefits.

In sum, this large‑scale analysis offers fresh evidence that the shingles vaccine is not only a guardian against painful rashes but also a potential ally against heart disease, stroke, and cognitive decline. As healthcare systems grapple with rising costs and aging populations, such findings may reshape how clinicians prioritize preventive measures and how patients perceive vaccination benefits.